Fulgent Genetics

From Verify.Wiki
Jump to: navigation, search
Fulgent Genetics
Type Public
Industry Biotechnology
Founded 2011
Headquarters Temple City, California 91780 United States
Key people Ming Hsieh (CEO), Han Lin Gao ( Chief Scientific Officer), Paul Kim (CFO) Cite error: Closing </ref> missing for <ref> tag

Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics. It focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016.
They have Accreditations from the following:

  • Clinical Laboratory Improvement Amendments (CLIA) License 2015-2017
  • College of American Pathologists (CAP) Accreditation 2017
  • California Clinical Laboratory License 2016
  • Florida Clinical Laboratory License 2016 - 2018
  • Pennsylvania Clinical Laboratory Permit 2016-2017
  • Maryland Medical Laboratory License 2015-2016



Top 5 Recent Tweets

May 16, 2022algobotnewsFulgent Genetics management to meet with Piper Sandler $FLGT
May 16, 2022fundamentalsbotFulgent Genetics, Inc's quarterly revenue growth rate YoY of -10.90% ranked 3463 out of 5730 companies in our datab… https://t.co/vPfCbPkaUV
May 03, 2022The_Real_FlyFulgent Genetics beats by $1.22, beats on revs; lowers FY22 EPS guidance below single analyst estimate, raises reve… https://t.co/E5ea0q7Ael

Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history